In recent trading, Concord Medical Services Holdings Limited (CCM, Financial) experienced significant stock movement with an 8.80% surge. The stock is currently priced at $5.44 per share, with a trading volume of 5,836 shares and a turnover rate of 0.13%. The stock's amplitude reached 16.80%.
According to the latest financial report, Concord Medical Services reported revenue of $30.32 million and a net loss of $23.87 million, translating to an earnings per share of -$5.46. The gross profit stood at -$5.76 million, with a price-to-earnings ratio of -0.46. Currently, no institutional ratings are available for this stock, including buy, hold, or sell recommendations.
Within the healthcare facilities industry, where CCM operates, the overall growth is 0.73%. Notable performers in the sector include Kindly Md Inc C/Wts 31/05/2029 (To Pur Com), Kindly Md, Inc., and The Oncology Institute, Inc., which have shown significant gains. Other active stocks in the sector include Kindly Md, Inc., The Oncology Institute, Inc., and Newgenivf Group Limited, with turnover rates of 79.89%, 9.66%, and 5.78%, respectively. Stocks with notable amplitude include P3 Health Partners Inc C/Wts 19/11/2026 (To Pur Com), Kindly Md Inc C/Wts 31/05/2029 (To Pur Com), and Kindly Md, Inc., with amplitudes of 344.00%, 65.30%, and 59.05%, respectively.
Concord Medical Services Holdings Limited operates radiation therapy and diagnostic imaging centers across various provinces and administrative regions in China. Their network includes centers for radiation therapy, diagnostic imaging, and other diagnostic services such as EEG for epilepsy, hyperthermia for enhancing radiotherapy and chemotherapy, high-intensity focused ultrasound for cancer treatment, and stereotactic radiofrequency ablation for Parkinson’s disease.
